Govt plans to ramp up production of Covaxin to 10 crore doses per month

NITI Aayog member Dr VK Paul said, total production of Covaxin doses will be further scaled up to 13 crore doses a month when three public sector undertakings start manufacturing the vaccine.

Centre has said that it plans to ramp up the production of Bharat Biotech’s Covaxin from 1.5 crore doses to about 10 crore doses every month.

NITI Aayog member Dr VK Paul said, total production of Covaxin doses will be further scaled up to 13 crore doses a month when three public sector undertakings start manufacturing the vaccine.

advt

Briefing media persons, he said that the government will look at more private players to scale up the production of Covaxin.

Haffkine Biopharmaceuticals in Mumbai, Indian Immunologicals in Hyderabad and Bulandshahr-based Bharat Immunologicals and Biologicals are the three public sector units that will manufacture Covaxin vaccine.

Dr Paul said, Bharat Biotech’s vaccine technology is being shared with the three PSUs with a provision of 150-crore rupees funding to scale up production.

Tags
advt

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button